{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:39:35Z","timestamp":1762508375055,"version":"3.40.4"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Chinese National Natural Science Foundation","doi-asserted-by":"crossref","award":["81700096; 8196010329; 81871736"],"award-info":[{"award-number":["81700096; 8196010329; 81871736"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bureau of traditional Chinese Medicine Scientific Research Project of Guangdong","award":["20192048"],"award-info":[{"award-number":["20192048"]}]},{"name":"Science and Technology Innovation Committee Project of Guangzhou","award":["201804020043"],"award-info":[{"award-number":["201804020043"]}]},{"name":"Key projects of Guangzhou Education Bureau","award":["201831802"],"award-info":[{"award-number":["201831802"]}]},{"name":"Open Project of State Key Laboratory of Respiratory Disease","award":["SKLRD-OP-201803, SKLRD-OP-201809"],"award-info":[{"award-number":["SKLRD-OP-201803, SKLRD-OP-201809"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Interstitial pneumonia with autoimmune features (IPAF) is a special subtype of interstitial lung disease that has received worldwide attention. Krebs von den Lungen-6 (KL-6) and surfactant protein-A (SP-A) can be used as an important biomarker of interstitial lung disease, but its exact relationship with IPAF is poorly understood.<\/jats:p>\n            <jats:p>A total of 65 IPAF patients were included in the study and were followed up for 52\u200aweeks. The KL-6 and SP-A were evaluated by chemiluminescence enzyme immunoassay. The above indicators were tested at 2 time points, baseline (the first admission of patients) and 52\u200aweeks. We also collected the indicators of antinuclear antibodies and rheumatoid factor. Based on high-resolution computed tomography evaluations, patients were divided into: aggravation, stable, and improvement group. At same time, 30 age-matched normal people as normal control were recruited, the same information was collected. Correlations among the groups were compared and analyzed.<\/jats:p>\n            <jats:p>The KL-6 and SP-A level in IPAF patients were significantly higher than normal controls (fold increase\u200a=\u200a11.35 and 1.39, both <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) and differed significantly at baseline and 52\u200aweeks in IPAF (difference ratio\u200a=\u200a37.7% and 21.3%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05, both). There were significant differences at baseline and 52\u200aweeks (<jats:italic toggle=\"yes\">r<\/jats:italic> values of aggravation, improvement, and stable groups for KL-6 were 0.705, 0.770, and 0.344, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.001, .001, and .163, and for SP-A the <jats:italic toggle=\"yes\">r<\/jats:italic> value were 0.672, 0.375, and 0.316, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.001, .126, and .152). In aggravation group, KL-6 and SP-A were correlated with CT scores (both <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). Diffusing capacity of the lung for carbon monoxide (DLCO) and forced vital capacity (FVC), % predicted showed a progressive downward trend, with a significant difference at baseline and 52\u200aweeks in IPAF patients (difference ratio\u200a=\u200a23.8% and 20.6%, both <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). There was a significant correlation between KL-6 and FVC % predicted and DLCO (both <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05), SP-A showed negatively correlated with DLCO, but not significantly correlated with FVC % predicted (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05 and .47).<\/jats:p>\n            <jats:p>This study demonstrated that KL-6 and SP-A can reflect disease progression, and both 2 play a key role at reflection of lung epithelial cell injury and fibrosis degree in IPAF.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024260","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T10:01:28Z","timestamp":1611914488000},"page":"e24260","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Krebs von den Lungen-6 and surfactant protein-A in interstitial pneumonia with autoimmune features"],"prefix":"10.1097","volume":"100","author":[{"given":"Mingshan","family":"Xue","sequence":"first","affiliation":[{"name":"Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanxu","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Shenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital, First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifeng","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huai","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haisheng","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luqian","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1671-0723","authenticated-orcid":false,"given":"Baoqing","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1513\/AnnalsATS.201808-565CME","article-title":"Interstitial pneumonia with autoimmune features","volume":"16","author":"Graney","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/resp.13254","article-title":"Overlap of interstitial pneumonia with autoimmune features with undifferentiated connective tissue disease and contribution of UIP to mortality","volume":"23","author":"Kelly","year":"2018","journal-title":"Respirology"},{"key":"R3-20250504","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02519-2017","article-title":"Cyclophosphamide in steroid refractory unclassifiable idiopathic interstitial pneumonia and interstitial pneumonia with autoimmune features (IPAF)","volume":"51","author":"Wiertz","year":"2018","journal-title":"Eur Respir J"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3389\/fmed.2019.00209","article-title":"Interstitial pneumonia with autoimmune features (IPAF)","volume":"6","author":"Fernandes","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12890-019-0868-9","article-title":"Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis","volume":"19","author":"Lim","year":"2019","journal-title":"BMC Pulm Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-0039-1684007","article-title":"Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease","volume":"40","author":"Chernau","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.rmed.2016.12.014","article-title":"Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS\/ERS criteria for interstitial pneumonia with autoimmune features (IPAF)","volume":"123","author":"Mejia","year":"2017","journal-title":"Respir Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"e-75","DOI":"10.1515\/cclm-2019-0648","article-title":"The chaos of serologic markers in interstitial pneumonia with autoimmune features can be corrected by the laboratory physician","volume":"58","author":"Jearn","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ccm.2019.05.007","article-title":"Interstitial pneumonia with autoimmune features","volume":"40","author":"Fischer","year":"2019","journal-title":"Clin Chest Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.chest.2018.08.1074","article-title":"POINT: does interstitial pneumonia with autoimmune features represent a distinct class of patients with idiopathic interstitial pneumonia?","volume":"155","author":"Lee","year":"2019","journal-title":"Yes Chest"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00296-018-3987-3","article-title":"Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease","volume":"38","author":"Benyamine","year":"2018","journal-title":"Rheumatol Int"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.rmed.2015.10.005","article-title":"The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis","volume":"109","author":"Okamoto","year":"2015","journal-title":"Respir Med"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ijc.26007","article-title":"Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer","volume":"130","author":"Tanaka","year":"2012","journal-title":"Int J Cancer"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s10067-019-04501-9","article-title":"Serum KL-6 is associated with the severity of interstitial lung disease in Chinese patients with polymyositis and dermatomyositis","volume":"38","author":"Hu","year":"2019","journal-title":"Clin Rheumatol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3389\/fimmu.2019.01960","article-title":"Differential impact of co-expressed SP-A1\/SP-A2 protein on AM miRNome; sex differences","volume":"10","author":"Thorenoor","year":"2019","journal-title":"Front Immunol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"105936","DOI":"10.1016\/j.intimp.2019.105936","article-title":"SP-A and TLR4 localization in lung tissue of SM-exposed patients","volume":"80","author":"Ghaffarpour","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/art.41020","article-title":"Progression of interstitial lung disease in systemic sclerosis: the importance of pneumoproteins Krebs von den Lungen 6 and CCL18","volume":"71","author":"Volkmann","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13075-019-1835-9","article-title":"Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease","volume":"21","author":"Lee","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1080\/1744666X.2020.1670062","article-title":"Biomarkers of skin and lung fibrosis in systemic sclerosis","volume":"15","author":"Martinovic Kaliterna","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"e1086","DOI":"10.1002\/cti2.1086","article-title":"Idiopathic and immune-related pulmonary fibrosis: diagnostic and therapeutic challenges","volume":"8","author":"McLean-Tooke","year":"2019","journal-title":"Clin Transl Immunology"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1159\/000503689","article-title":"Evaluation of the diagnostic efficacies of serological markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in idiopathic interstitial pneumonia","volume":"98","author":"Xue","year":"2019","journal-title":"Respiration"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12931-019-1190-z","article-title":"Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry","volume":"20","author":"Todd","year":"2019","journal-title":"Respir Res"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/art.41123","article-title":"Comparative profiling of serum protein biomarkers in rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis","volume":"72","author":"Kass","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.resinv.2019.03.006","article-title":"Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia","volume":"57","author":"Yamakawa","year":"2019","journal-title":"Respir Investig"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"672520","DOI":"10.1155\/2015\/672520","article-title":"Enhanced classification of interstitial lung disease patterns in HRCT images using differential lacunarity","volume":"2015","author":"Vasconcelos","year":"2015","journal-title":"Biomed Res Int"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.21037\/jtd.2018.07.76","article-title":"Sequential changes of serum KL-6 predict the progression of interstitial lung disease","volume":"10","author":"Jiang","year":"2018","journal-title":"J Thorac Dis"},{"key":"R27-20250504","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8081199","article-title":"Correlation between transthoracic lung ultrasound score and HRCT features in patients with interstitial lung diseases","volume":"8","author":"Man","year":"2019","journal-title":"J Clin Med"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10067-015-2866-5","article-title":"HRCT score and serum ferritin level are factors associated to the 1-year mortality of acute interstitial lung disease in clinically amyopathic dermatomyositis patients","volume":"34","author":"Zou","year":"2015","journal-title":"Clin Rheumatol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CPM.0000000000000227","article-title":"Interstitial pneumonia with autoimmune features: overview of proposed criteria and recent cohort characterization","volume":"24","author":"Lee","year":"2017","journal-title":"Clin Pulm Med"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1183\/13993003.01565-2015","article-title":"Characterisation of patients with interstitial pneumonia with autoimmune features","volume":"47","author":"Oldham","year":"2016","journal-title":"Eur Respir J"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.2169\/internalmedicine.50.5866","article-title":"Serum KL-6 level as an indicator of active or inactive interstitial pneumonitis associated with connective tissue diseases","volume":"50","author":"Doishita","year":"2011","journal-title":"Intern Med"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.21037\/jtd.2018.07.54","article-title":"Diagnostic value of KL-6 in idiopathic interstitial pneumonia","volume":"10","author":"Zheng","year":"2018","journal-title":"J Thorac Dis"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clim.2018.12.013","article-title":"Autoimmune interstitial lung disease in Latin-America","volume":"199","author":"Vivero","year":"2019","journal-title":"Clin Immunol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/art.40783","article-title":"Diagnostic pitfalls and treatment challenges in interstitial pneumonia with autoimmune features: comment on the article by Wilfong et al","volume":"71","author":"Novikov","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/art.40679","article-title":"Interstitial pneumonia with autoimmune features: an emerging challenge at the intersection of rheumatology and pulmonology","volume":"70","author":"Wilfong","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.rmed.2019.03.011","article-title":"Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients","volume":"150","author":"Sambataro","year":"2019","journal-title":"Respir Med"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.5858\/arpa.2017-0528-RA","article-title":"Morphologic aspects of interstitial pneumonia with autoimmune features","volume":"142","author":"Nascimento","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R38-20250504","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0102-2017","article-title":"Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease","volume":"27","author":"Caron","year":"2018","journal-title":"Eur Respir Rev"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"38949","DOI":"10.1038\/srep38949","article-title":"Clinical association of chemokine (C-X-C motif) ligand 1 (CXCL1) with interstitial pneumonia with autoimmune features (IPAF)","volume":"6","author":"Liang","year":"2016","journal-title":"Sci Rep"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00408-019-00276-7","article-title":"Clinical characteristics and natural history of autoimmune forms of interstitial lung disease: a single-center experience","volume":"197","author":"Chartrand","year":"2019","journal-title":"Lung"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/rheumatology\/key420","article-title":"Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung disease","volume":"58","author":"Takanashi","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"e13542","DOI":"10.1097\/MD.0000000000013542","article-title":"Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody: a retrospective cohort study","volume":"97","author":"Yamaguchi","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"e23070","DOI":"10.1002\/jcla.23070","article-title":"Evaluation of the clinical performance of the HISCL-5000 analyzer in the detection of Krebs von den Lungen-6 antigen and its diagnostic value in interstitial lung disease","volume":"34","author":"Wang","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12931-019-1172-1","article-title":"Surfactant protein A in particles in exhaled air (PExA), bronchial lavage and bronchial wash - a methodological comparison","volume":"20","author":"Behndig","year":"2019","journal-title":"Respir Res"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000504763","article-title":"Idiopathic pulmonary fibrosis: best practice in monitoring and managing a relentless fibrotic disease","volume":"99","author":"Wuyts","year":"2020","journal-title":"Respiration"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/rheumatology\/kez571","article-title":"Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease","volume":"59","author":"Wang","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1378\/chest.127.1.403","article-title":"Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease","volume":"127","author":"Al-Salmi","year":"2005","journal-title":"Chest"},{"key":"R48-20250504","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0139-2017","article-title":"State of the art in interstitial pneumonia with autoimmune features: a systematic review on retrospective studies and suggestions for further advances","volume":"27","author":"Sambataro","year":"2018","journal-title":"Eur Respir Rev"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.rmed.2016.01.019","article-title":"The use of auto-antibody testing in the evaluation of interstitial lung disease (ILD)--A practical approach for the pulmonologist","volume":"113","author":"Bahmer","year":"2016","journal-title":"Respir Med"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s10067-019-04906-6","article-title":"Characteristics of patients with primary Sjogren's syndrome associated interstitial lung disease and relevant features of disease progression","volume":"39","author":"Zhang","year":"2020","journal-title":"Clin Rheumatol"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.rmed.2016.09.002","article-title":"Clinical features and natural history of interstitial pneumonia with autoimmune features: a single center experience","volume":"119","author":"Chartrand","year":"2016","journal-title":"Respir Med"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J Intern Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:30:03Z","timestamp":1746340203000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024260","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"2020-04-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}